| For: | Echeverría N, Comas V, Aldunate F, Perbolianachis P, Moreno P, Cristina J. In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet? . World J Hepatol 2021; 13(10): 1234-1268 [PMID: 34786164 DOI: 10.4254/wjh.v13.i10.1234] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v13/i10/1234.htm |
| Number | Citing Articles |
| 1 |
Christian Tague, Johan Domga, Ayesha Junaid, Okhesomi Rejoice Eshemokhai, Josias Kamgang Silatchom, Criss Koba Mjumbe. Primary Cancer Prevention Through Vaccination: Advances, Challenges, and Global Perspectives. Health Science Reports 2026; 9(6) doi: 10.1002/hsr2.72666
|
| 2 |
Ashraf Elbahrawy, Hassan Atalla, Mohamed Alboraie, Ahmed Alwassief, Ali Madian, Mohammed El Fayoumie, Ashraf A. Tabll, Hussein H. Aly. Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review. Viruses 2023; 15(1) doi: 10.3390/v15010214
|
| 3 |
Amirhosein Faghihkhorasani, Hanan Hassan Ahmed, Noor Muhammad Mashool, Mariem Alwan, Marjan Assefi, Aya Hussein Adab, Saman Yasamineh, Omid Gholizadeh, Moein Baghani. The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection. Virology Journal 2023; 20(1) doi: 10.1186/s12985-023-02183-z
|
| 4 |
Nahla A. Hussein, Rasha A. M. Azouz, Reem El-Shenawy, Naiera M. Helmy, Ashraf A. Tabll, Yasmine S. El-Abd, Ahmed A. Ali. A virus-like-particle-producing DNA vaccine triggers specific humoral immunity against hepatitis C virus in mice. Archives of Virology 2025; 170(12) doi: 10.1007/s00705-025-06419-x
|
| 5 |
Zhuang Li, Yuan Zhang, Yiyang Zheng, Hongyu Wang, Chenyang Xu, Qing He. Therapeutic Vaccines for Chronic Viral Infections: From Immune Modulation to Clinical Translation. Vaccines 2026; 14(6) doi: 10.3390/vaccines14060507
|
| 6 |
Kainat Ahmed, Sudhakar Jha. Oncoviruses: How do they hijack their host and current treatment regimes. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023; 1878(5) doi: 10.1016/j.bbcan.2023.188960
|
| 7 |
Victor Kupriyanov, Lyudmila Nikolaeva, Alexander Grishechkin, Evgeny Samokhvalov, Anna Dedova, Anna Zykova, Nikolai Ravin. Dendritic cells derived from induced pluripotent stem cells and stimulated by antigens of hepatitis C virus efficiently activate T-lymphocytes. Journal of Biosciences 2024; 49(4) doi: 10.1007/s12038-024-00469-0
|
| 8 |
Ahmed A. Ali, Ashraf A. Tabll. Unlocking potential: Virus-like particles as a promising strategy for effective HCV vaccine development. Virology 2025; 602 doi: 10.1016/j.virol.2024.110307
|
| 9 |
Rafid Jihad Albadr, Hayder Naji Sameer, Zainab H. Athab, Mohaned Adil, Ahmed Yaseen, Omer Qutaiba B. Allela. Recent Advances in mRNA-Based Vaccines Against Several Hepatitis Viruses. Biological Procedures Online 2025; 27(1) doi: 10.1186/s12575-025-00269-2
|
| 10 |
A. Kouakou Viviane, Sevede Daouda, Doumbia Moussa, E. Assohoun Stanislas, Dosso Mireille. Evaluation of viral hepatitis C screening at Institut Pasteur of Cte dIvoire from 2012 to 2022. African Journal of Biotechnology 2023; 22(11) doi: 10.5897/AJB2023.17615
|
| 11 |
Laura Cardoso Corrêa-Dias, Ágata Lopes-Ribeiro, Geovane Marques-Ferreira, Letícia Gomes-de-Pontes, Thaiza Aline Pereira-Santos, Erik Vinicius de Sousa Reis, Thaís de Fátima Silva Moraes, Olindo Assis Martins-Filho, Edel Figueiredo Barbosa-Stancioli, Flávio Guimarães da Fonseca, Jordana Grazziela Coelho-dos-Reis. HCV immunodominant peptide mapping reveals unique HLA-A*02-restricted signatures: insights for CD8+ T-cell-based vaccines and immunotherapies. Immunogenetics 2025; 77(1) doi: 10.1007/s00251-025-01370-2
|
| 12 |
Roba Dabour, Shaked Bergman, Zohar Zafrir, Ateret Davidovitch, Michal Werbner, Meital Gal-Tanamy, Tamir Tuller. Silent mutations in coding regions of Hepatitis C virus affect patterns of HCV RNA structures and attenuate viral replication and pathogenesis. Genome Biology 2025; 26(1) doi: 10.1186/s13059-025-03816-y
|
| 13 |
Noura M. Alshiban, Munirah S. Aleyiydi, Majed S. Nassar, Nada K. Alhumaid, Thamer A. Almangour, Yahya M.K. Tawfik, Laila A. Damiati, Abdulaziz S. Almutairi, Essam A. Tawfik. Epidemiologic and clinical updates on viral infections in Saudi Arabia. Saudi Pharmaceutical Journal 2024; 32(7) doi: 10.1016/j.jsps.2024.102126
|
| 14 |
Alia Alassad, Mhd Jawad Al Rahwanji, Amal Yousfan, Sally Al Moualem, Arwa Farhat, Lama A. Youssef. Seroprevalence and trends of hepatitis B virus, hepatitis C virus and human immunodeficiency virus in Syrian blood donors at Damascus University Blood Center between 2004 and 2021. Frontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1174638
|
| 15 |
Ahmed Saati, Faisal M. Sanai. Direct-Acting Antivirals against Hepatitis C. 2026; doi: 10.1016/B978-0-443-41363-6.00003-2
|
| 16 |
Ashraf A. Tabll, Sayed S. Sohrab, Ahmed A. Ali, Ana Petrovic, Sabina Steiner Srdarevic, Stjepan Siber, Marija Glasnovic, Robert Smolic, Martina Smolic. Future Prospects, Approaches, and the Government’s Role in the Development of a Hepatitis C Virus Vaccine. Pathogens 2023; 13(1) doi: 10.3390/pathogens13010038
|
| 17 |
Paola Moreno Lozano, Lilia Angélica Hurtado Ayala, Francisco Guillermo Mendoza-Hoffmann, Bertha Landeros Sanchez. Hepcidin levels in healthy young adults: Findings from a systematic review and meta-analysis of reference intervals. Journal of Diabetes & Metabolic Disorders 2026; 25(1) doi: 10.1007/s40200-025-01854-8
|
| 18 |
Yen T. K. Nguyen, Fang Chen, Erick Giang, Swati Saha, Lynn A. Ueno, Christopher Chen, Corey T. Watson, Netanel Tzarum, Ian A. Wilson, Mansun Law, Robyn L. Stanfield. Structural and genetic signatures of two classes of HCV E2 neutralizing face antibodies from non-human primates immunized with a recombinant E1E2. npj Vaccines 2026; doi: 10.1038/s41541-026-01449-1
|
| 19 |
Olga Szostek, Patrycja Schorsch, Daniela Bender, Mirco Glitscher, Eberhard Hildt. The HCV-Dependent Inhibition of Nrf1/ARE-Mediated Gene Expression Favours Viral Morphogenesis. Viruses 2025; 17(8) doi: 10.3390/v17081052
|